Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Immunovia AB ( (SE:IMMNOV) ) has shared an announcement.
Immunovia AB has announced a directed issue of 32,674,998 shares to guarantors as part of a compensation agreement related to a previously completed rights issue. This move is aimed at fulfilling obligations to guarantors who opted for shares instead of cash, thereby strengthening the company’s working capital and financial position while resulting in a 4.9% dilution effect.
More about Immunovia AB
Immunovia AB is a company operating in the biotechnology industry, focusing on developing diagnostic solutions for complex diseases. The company is known for its innovative approaches in the early detection of diseases, which positions it as a significant player in the healthcare diagnostics market.
Average Trading Volume: 10,024,530
Technical Sentiment Signal: Sell
Current Market Cap: SEK218.9M
For detailed information about IMMNOV stock, go to TipRanks’ Stock Analysis page.